Clinical Trial Update: De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) [Phase 3]

View source ↗

Summary

A Phase 3 trial (DEBRA) assesses de-escalation of breast radiation in hormone receptor-positive, HER2-negative breast cancer with Oncotype RS ≤ 18; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Stage I Breast Cancer | Phase 3 | Status: RECRUITING